What Researchers Did
Researchers conducted a randomised controlled trial to evaluate hyperbaric oxygen therapy combined with pharmacologic treatment for keratoendotheliosis secondary to surgical treatment.
What They Found
Of 33 patients, 12 received hyperbaric oxygen daily for ten days alongside pharmacologic therapy, while 21 received pharmacologic therapy alone. Hyperbaric oxygen treatment effectively reduced corneal oedema, especially when administered early, and prevented corneal neovascularization in all treated patients.
Canadian Relevance
This study does not report any direct Canadian connection or involvement.
Study Limitations
Limitations include the small sample size of 33 patients and the imbalance between the two treatment arms.